Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.
van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ, Haanen HC, Hofman DM, van Albada-Kuipers GA, ter Borg EJ, Brus HL, Dinant HJ, Kruize AA, Schenk Y. van der Heide A, et al. Among authors: van booma frankfort c, van albada kuipers ga, van der veen mj. Ann Intern Med. 1996 Apr 15;124(8):699-707. doi: 10.7326/0003-4819-124-8-199604150-00001. Ann Intern Med. 1996. PMID: 8633829 Clinical Trial.
Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.
Nair SC, Bijlsma JW, van der Werf JH, van der Veen MJ, Linn-Rasker SP, Vreugdenhil S, Lafeber FP, Welsing PM. Nair SC, et al. Among authors: van der veen mj. J Rheumatol. 2013 Sep;40(9):1505-12. doi: 10.3899/jrheum.121346. Epub 2013 Jul 1. J Rheumatol. 2013. PMID: 23818710 Clinical Trial.
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
Bakker MF, Jacobs JW, Welsing PM, Verstappen SM, Tekstra J, Ton E, Geurts MA, van der Werf JH, van Albada-Kuipers GA, Jahangier-de Veen ZN, van der Veen MJ, Verhoef CM, Lafeber FP, Bijlsma JW; Utrecht Rheumatoid Arthritis Cohort Study Group. Bakker MF, et al. Among authors: van der veen mj. Ann Intern Med. 2012 Mar 6;156(5):329-39. doi: 10.7326/0003-4819-156-5-201203060-00004. Ann Intern Med. 2012. PMID: 22393128 Free article. Clinical Trial.
Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.
Bakker MF, Jacobs JW, Kruize AA, van der Veen MJ, van Booma-Frankfort C, Vreugdenhil SA, Bijlsma JW, Lafeber FP, Welsing PM. Bakker MF, et al. Among authors: van der veen mj. Ann Rheum Dis. 2012 Jun;71(6):830-5. doi: 10.1136/annrheumdis-2011-146670. Epub 2011 Nov 29. Ann Rheum Dis. 2012. PMID: 22128075
Look beyond the disease activity score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritis.
Ton E, Bakker MF, Verstappen SM, Ter Borg EJ, van Albada-Kuipers IA, Schenk Y, van der Veen MJ, Bijlsma JW, Jacobs JW; Utrecht Rheumatoid Arthritis Cohort Study Group. Ton E, et al. Among authors: van der veen mj. J Rheumatol. 2012 Jan;39(1):22-7. doi: 10.3899/jrheum.110072. Epub 2011 Oct 15. J Rheumatol. 2012. PMID: 22002014
Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year.
Verstappen SM, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, Borg EJ, Hofman DM, van der Veen MJ; Utrecht Arthritis Cohort Study Group. Verstappen SM, et al. Among authors: van booma frankfort c, van der veen mj. Arthritis Rheum. 2003 Jul;48(7):1797-807. doi: 10.1002/art.11170. Arthritis Rheum. 2003. PMID: 12847672 Free article. Clinical Trial.
The relation between cartilage biomarkers (C2C, C1,2C, CS846, and CPII) and the long-term outcome of rheumatoid arthritis patients within the CAMERA trial.
Bakker MF, Verstappen SM, Welsing PM, Jacobs JW, Jahangier ZN, van der Veen MJ, Bijlsma JW, Lafeber FP; Utrecht Arthritis Cohort study group. Bakker MF, et al. Among authors: van der veen mj. Arthritis Res Ther. 2011 May 8;13(3):R70. doi: 10.1186/ar3331. Arthritis Res Ther. 2011. PMID: 21539729 Free PMC article. Clinical Trial.
Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
van der Goes MC, Jacobs JW, Jurgens MS, Bakker MF, van der Veen MJ, van der Werf JH, Welsing PM, Bijlsma JW. van der Goes MC, et al. Among authors: van der veen mj. Osteoporos Int. 2013 Apr;24(4):1429-36. doi: 10.1007/s00198-012-2073-z. Epub 2012 Aug 2. Osteoporos Int. 2013. PMID: 23011680 Free PMC article. Clinical Trial.
Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study.
Bakker MF, Jacobs JW, Welsing PM, van der Werf JH, Linn-Rasker SP, van der Veen MJ, Lafeber FP, Bijlsma JW; Utrecht Arthritis Cohort Study Group. Bakker MF, et al. Among authors: van der werf jh, van der veen mj. Ann Rheum Dis. 2010 Oct;69(10):1849-52. doi: 10.1136/ard.2009.124065. Epub 2010 May 28. Ann Rheum Dis. 2010. PMID: 20511610 Clinical Trial.
46 results